Morgan Cantley, PharmD, BCOP
Advertisement
Articles by Morgan Cantley, PharmD, BCOP
Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan.
Advertisement
Latest Updated Articles
Trastuzumab and HER2-Targeted Therapy: Breaking Down the BasicsAugust 15th 2025
Advertisement
Advertisement
Trending on Pharmacy Times
1
VAX-31 Meets All Primary End Points vs PCV20 and PCV21 in Pivotal Phase 3 OPUS-1 Trial
2
Peptide Compounding Is Evolving: What Pharmacists Need to Know Now
3
Fall 2026 Quiz: Test Your Pharmacy Knowledge!
4
Pharmacists Positioned as Key Educators as Monoclonal Antibodies Emerge as COVID-19 Immunization Option
5